VBI Vaccines Inc. (NASDAQ:VBIV)
Industry: Healthcare

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a prophylactic hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the structure of the target virus. It is also developing cytomegalovirus vaccine candidate for infectious disease; and glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts.

Current Quote*
Last: $1.545
Change: -0.095
Book: $3.046
Volume: 3,632,992

As Of: 01/22 13:02 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol VBIV

Graphs for VBIV


3 Month Graph


6 Month Graph


1 Year Graph